PROS1 and COVID-19: The cross-reactivities were further verified by Western blot with HCoV-OC43-positive plasma from unexposed healthy individuals which were collected before 2019 and SARS-CoV-2 S protein, as well as SARS-CoV-2 positive plasma from confirmed COVID-19 patients and HCoV-OC43 S protein.